@dnunan79 From @RobertCGreen and @Genomes2People MedSeq - https://t.co/IGq0UxSZy9 REVEAL (Alzheimer’s) - https://t.co/NagS9SX0M1 BabySeq - https://t.co/544DvcFUz0 2/4
RT @RobertCGreen: Fantastic! You can find all MedSeq publications here: https://t.co/qmLHKx9o5Q https://t.co/5GCP1V7DSU
RT @RobertCGreen: Fantastic! You can find all MedSeq publications here: https://t.co/qmLHKx9o5Q https://t.co/5GCP1V7DSU
RT @RobertCGreen: Fantastic! You can find all MedSeq publications here: https://t.co/qmLHKx9o5Q https://t.co/5GCP1V7DSU
Fantastic! You can find all MedSeq publications here: https://t.co/qmLHKx9o5Q
Green #AGBTph18 MedSeq '14 ref https://t.co/tqczQRo6bZ '14 ref on reports https://t.co/pdkImgIy2d PCP's became more comfortable with talking about this info
RT @DavidHongMD: Important study! https://t.co/VeOOds57F5
RT @SCSanderson: OK, today I’m taking a look at the psychological & physical health-related outcomes of personal results from whole-genome…
RT @SCSanderson: OK, today I’m taking a look at the psychological & physical health-related outcomes of personal results from whole-genome…
RT @SCSanderson: OK, today I’m taking a look at the psychological & physical health-related outcomes of personal results from whole-genome…
OK, today I’m taking a look at the psychological & physical health-related outcomes of personal results from whole-genome sequencing (WGS) being returned to generally healthy patients in the MedSeq project. https://t.co/YL4gfZN5jD #genomics
RT @EMBOSU: Genetic testing & results can have significant implications not only for your health & disease prevention; but also the risk st…
RT @ppisters: Pivotal MedSeq trial by @jasonvassy et al: randomized study of whole genome sequencing on downstream medical costs. Robust ev…
RT @DavidHongMD: Important study! https://t.co/VeOOds57F5
RT @EMBOSU: Genetic testing & results can have significant implications not only for your health & disease prevention; but also the risk st…
RT @DavidHongMD: Important study! https://t.co/VeOOds57F5
RT @ppisters: Pivotal MedSeq trial by @jasonvassy et al: randomized study of whole genome sequencing on downstream medical costs. Robust ev…
RT @EMBOSU: Genetic testing & results can have significant implications not only for your health & disease prevention; but also the risk st…
Genetic testing & results can have significant implications not only for your health & disease prevention; but also the risk status of family members. @GeneticCouns can help you navigate these complex situations, identify personalized approaches,
@katie_stoll @elo81 Thank you for sharing your reflections @elo81 ...shortly after reading your post, came across this publication & thought: described role of the GCs in this study undervalues their contributions (maybe misperception:any #GCChat colle
RT @ppisters: Pivotal MedSeq trial by @jasonvassy et al: randomized study of whole genome sequencing on downstream medical costs. Robust ev…
Important study! https://t.co/VeOOds57F5
RT @jasonvassy: And see PMID's 28654958, 29030401, and 29565423 for trial outcomes in primary care, cardiology, and costs. @Genomes2People…
RT @ppisters: Pivotal MedSeq trial by @jasonvassy et al: randomized study of whole genome sequencing on downstream medical costs. Robust ev…
And see PMID's 28654958, 29030401, and 29565423 for trial outcomes in primary care, cardiology, and costs. @Genomes2People https://t.co/zI4OgmMYJz
RT @ppisters: Pivotal MedSeq trial by @jasonvassy et al: randomized study of whole genome sequencing on downstream medical costs. Robust ev…
RT @ppisters: Pivotal MedSeq trial by @jasonvassy et al: randomized study of whole genome sequencing on downstream medical costs. Robust ev…
Pivotal MedSeq trial by @jasonvassy et al: randomized study of whole genome sequencing on downstream medical costs. Robust evidence to demonstrate that costs did not significantly differ between patients who had received WGS and those that did not. https:/
@SteveJoffe @jasonvassy @RobertCGreen @Genomes2People What is the rationale for randomizing if study wasn't designed to have stat power for any primary outcomes? https://t.co/yO3ATW6kxK #lottery
.@robertcgreen The MedSeq project: https://t.co/h07vJOFabL on integrating WGS into clinical practice still faces GINA concerns #UYG
.@RobertCGreen presenting on his MedSeq genome study. Learn more about his research: http://t.co/QuLIYCq5rh & http://t.co/95vUkt2fyF #UYG
.@RobertCGreen presenting on his MedSeq genome study. Learn more about his research: http://t.co/QuLIYCq5rh & http://t.co/95vUkt2fyF #UYG
.@RobertCGreen presenting on his MedSeq study. Learn more on the project & reporting. http://t.co/QuLIYCq5rh & http://t.co/95vUkt2fyF #UYG
H. Rehm: MedSeq Project (http://t.co/edGnaOIQve) randomized trial: whole genome seq vs standard of care with family history #ASHG14
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
H. Rehm: MedSeq Project (http://t.co/edGnaOIQve) randomized trial: whole genome seq vs standard of care with family history #ASHG14
Heidi Rehm on MedSeq project; 100 healthy, 100 Hypertrophic cardiomyopathy patients get WGS, compare outcomes #ASHG14 http://t.co/9WQqEnGaZR
.@markmccarthyoxf …and @genomes2people’s current RCT of whole genome sequencing, the MedSeq Project: http://t.co/t2rWm0sXpS
.@markmccarthyoxf …and @genomes2people’s current RCT of whole genome sequencing, the MedSeq Project: http://t.co/t2rWm0sXpS
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. http://t.co/35bMSMkoZL
The MedSeq Project: a randomized trial of integrating whole #genome sequencing into clinical medicine http://t.co/nsnmFZAwss #genomics
The MedSeq Project: a randomized trial of integrating whole #genome sequencing into clinical medicine http://t.co/nsnmFZAwss #genomics
The MedSeq Project: a randomized trial of integrating whole #genome sequencing into clinical medicine http://t.co/nsnmFZAwss #genomics
The MedSeq Project: a randomized trial of integrating whole #genome sequencing into clinical medicine http://t.co/nsnmFZAwss #genomics